KC-1451

CT26-EGFR Cell Line

×
22165
Home » Cell Lines » CT26-EGFR Cell Line

Background of CT26-EGFR Cell Line

Epidermal growth factor receptor (EGFR), also known as HER1 or ERBB1, is a transmembrane receptor tyrosine kinase of the ERBB family. It is expressed on epithelial cells and, upon binding epidermal growth factor, activates RAS-RAF-MEK-ERK and PI3K-AKT signaling that drives proliferation, survival and migration. EGFR is frequently overexpressed or mutated in carcinomas including non-small-cell lung cancer, colorectal cancer and head and neck cancer, and it is a validated target of tyrosine kinase inhibitors and of therapeutic antibodies such as cetuximab and panitumumab.

Specifications

Catalog NumberKC-1451
Cell Line NameCT26-EGFR Cell Line
NCBI/UniProt Accession NumberNM_005228
Clone Number2-5#
Host Cell LineCT26
DescriptionThe CT26-EGFR cell line stably overexpresses human EGFR on a murine colon carcinoma background
QuantityOne vial of frozen cells (≥2×106 cells)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% RPMI1640+20%FBS+10%DMSO
Propagation MediumRPMI1640+10%FBS+10µg/mL Puromycin
Selection MarkerPuromycin
MorphologyEpithelial-like
SubcultureSplit at a ratio of 1:4–1:8 every 2–3 days
Incubation37 °C with 5% CO2
StorageLiquid nitrogen immediately upon receiving
Doubling TimeEstimated 28 hours
Mycoplasma StatusNegative
In Vivo ValidationNA

Cell Line Generation

The CT26-EGFR cell line was generated using a lentiviral vector expressing the human EGFR sequence.

Characterization

Figure 1: Characterization of human EGFR overexpression in the CT26-EGFR stable clone using FACS.

Cell Resuscitation

  1. Pre-warm complete culture medium (basal medium and 10% FBS) in a 37°C water bath.
  2. Rapidly thaw the cryovial in a 37°C water bath for 1-2 minutes with gentle agitation.
  3. Transfer the vial to a biosafety cabinet, and disinfect the exterior with 70% ethanol.
  4. Aseptically transfer the cell suspension dropwise into a sterile centrifuge tube containing 9.0 mL of pre-warmed complete medium.
  5. Centrifuge at approximately 125 × g for 5–7 minutes at room temperature, carefully aspirate the supernatant without disturbing the cell pellet.
  6. Gently resuspend the pellet in an appropriate volume of complete medium and transfer the suspension into a T25 flask.
  7. Incubate the flask in a 37°C in a humidified 5% CO₂ incubator.
  8. Assess cell viability and morphology after 24 hours. If cells appear healthy, replace the medium with fresh medium supplemented with the appropriate selective antibiotic.
  9. Subculture the cells at a ratio of 1:4–1:8 every 2–3 days upon reaching 80%–90% confluency.

Cell Freezing

  1. Prepare the freezing medium (70% basal medium, 20% FBS and 10% DMSO) freshly before use.
  2. Pre-chill the freezing medium on ice and label the cryovials accordingly.
  3. Transfer the cell suspension to a sterile conical tube and perform a cell count to determine total viability and density.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature; carefully aspirate the supernatant.
  5. Gently resuspend the pellet in chilled freezing medium, ensuring a minimum cell density of 3×10⁶ cells/mL.
  6. Aliquot 1 mL of the cell suspension into each pre-labeled cryovial.
  7. Place the cryovials into a CoolCell® container and store at -80°C overnight for controlled-rate cooling.
  8. Transfer the cryovials to the liquid nitrogen for long-term storage the following day.

References

  1. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nature Reviews Molecular Cell Biology. 2001.
  2. Sigismund S, Avanzato D, Lanzetti L. Emerging functions of the EGFR in cancer. Molecular Oncology. 2018.
  3. Wee P, Wang Z. Epidermal growth factor receptor cell proliferation signaling pathways. Cancers. 2017.

Use License Agreement

Research Use Only.
Not for use in diagnostic procedures or therapeutic applications.
Redistribution of the cell line or its derivatives is prohibited without prior written permission from Kyinno Biotechnology.